Part 8: Pharmacovigilance and Regulatory Affairs

Who should attend: All clinical trial stakeholders, including sites, sponsors and CROs, HREC & governance officers.

In response to the risk to clinical trials, ARCS is running free weekly webinars focused on COVID-19. These are going to be highly effective in helping everyone understand what is happening and what strategies different groups are adopting to keep our trials going as effectively as possible. The webinar series is called 'COVID-19: considerations and strategies for running trials during the pandemic'.

The purpose of this webinar series is to provide information, advice, and a chance to discuss how COVID-19 will impact clinical trials in Australia. There will be 10 webinars, each targeted at a different clinical trials area, as follows:

23-Mar-2020: Part 1  - Investigators and Study Coordinators

31-Mar-2020: Part 2 - Peak Bodies and TGA

06-Apr-2020: Part 3 - Jurisdictions: Federal/States

20-Apr-2020: Part 4 - Ethics Committees and Governance

28-Apr-2020: Part 5 - Role of Clinical Trial Sponsors

04-May-2020: Part 6 – Academics

11-May-2020: Part 7 – Private Sector

18-May-2020: Part 8 - Pharmacovigilance and Regulatory Affairs

25-May-2020: Part 9 - Clinical Trials for COVID-19 Treatment and Prevention

01-Jun-2020: Part 10 – Trial Participants

Please direct all questions regarding this webinar and its content to: arcs@arcs.com.au